The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH MDS 2024 | The unmet needs of patients with VEXAS syndrome
Maël Heiblig, MD, Hôpital Lyon Sud, Lyon, France, discusses the unmet needs of patients with VEXAS syndrome. To date, no prospective data has been collected, highlighting a need for developing clinical trials to determine effective treatment options for these patients. This interview took place at the European School of Hematology 9th Translational Research Conference on Myelodysplastic Syndromes (ESH MDS) in Budapest, Hungary.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
